INTRODUCTION
Patents have become financial assets. They are valued like securities, 1 traded like stocks,2 and modeled as options.
3 Our discourse about patents increasingly draws from finance. Firms whose business models depend on patent assertion explain that they are providing "liquidity" to the patent market.
4 Those on the other side, which engage in collective defense, talk about using the market to mitigate "patent risk. "
5 Commentators who ordinarily take very different positions about the merits of our current patent system seem to agree that we should make patent markets more efficient.
6
But neither they nor most others ask the logically prior question: should there be robust patent markets at all? This Essay provides a roadmap for answering that question. Taking seriously the analogy between patent markets and financial markets, I demonstrate that there are numerous
The kind of robust, liquid patent markets that this. Essay describes do not yet exist.11 But they are beginning to emerge.12 Consider just a few examples of recent patent transactions. In 2011, a consortium led by Apple and Microsoft purchased over 6000 patents from Nortel Networks, a bankrupt telecommunications firm, for $4.5 billion. 13 Three years later, that consortium sold 4000 of those patents to a syndicate of thirty different companies in a deal valued at $900 million and brokered by RPX, a patent intermediary.
14 Patents appeared to drive Google's 2011 purchase of Motorola Mobility for $12.5 billion, which included a portfolio of 24,500 pending or issued patents. 15 In 2012, Alcatel-Lucent refinanced $2.1 billion in debt in a collateralized offering secured primarily by its patent portfolio. 16 Heeding a popular call to "tap their patent portfolios for the hidden asset values and revenue streams that lie within," 17 many companies have spun off new entities whose sole purpose is to hold and monetize their patent 12. Some refer to this emerging market as a "secondary market" for patents. See, e.g.,
FED. TRADE COMM'N, THE EVOLVING IP MARKETPLACE: ALIGNING PATENT NOTICE AND REMEDIES WITH COMPETITION 58 (2011) [hereinafter FTC REPORT]
. That may be something of a misnomer. In finance, secondary markets are those which arise to facilitate the purchase and sale of securities after they have been issued in the primary market. Because a patent issues to an applicant rather than to a bidder in a market, there is no primary market for patents. Nevertheless, the term may be used interchangeably to signify purchases and sales among those other than the applicant to whom the patent initially issues. portfolios. 18 Others have sold their patents outright either to other operating companies or a whole new class of enterprises 19 -patent assertion entities; more pejoratively, patent trolls-that "purchase patents, and then sell or license them as assets whose values are based on the amount of licensing fees" or litigation recoveries they can obtain. 2° Finally, intermediaries have arisen to facilitate these transactions. Ocean Torno, for example, links buyers and sellers of patents through an auction process, 21 while a company called IPXI purported to create "the world's first financial exchange that facilitates non-exclusive licensing and trading of intellectual property (IP) rights with market-based pricing and standardized terms." 22 In short, patents no longer are used solely to exclude competitors; instead, they frequently are bought and sold by persons or entities other than the inventors whose work falls within the patent claims.
More important, the growth of this market is leading to a significant shift in the discourse, in which patents are treated not as classic incentives for innovation, but as financial assets. After all, they meet the typical definition of financial assets-they are transferable "claim[s] to future cash flow [s] ." 23 ,- The right to exclude conferred by a patent can generate cash for its holder when the underlying subject matter is licensed to others or the right to exclude is enforced through litigation. To be sure, the cash flow associated with any given patent is highly uncertain. 24 It depends on the vagaries of licensing negotiations or litigation. But valuation amidst significant uncertainty is what much of finance tries to accomplish, 25 and a number of methods have been developed to assign a monetary value to a patent. 26 Much of the academic commentary on these developments has focused on how to improve the operation of this nascent market. Nathan Myhrvold and Mark Lemley, for example, argue that price transparency is the sine qua non of a sustainable market and that in order to "make a patent market," patent assignment and license terms should be subject to mandatory disclosure. 27 Michael Risch argues in a similar vein that the securities laws ought to apply to patent portfolios. 28 In the public discourse about "patent trolls," many entities accused of trolling behavior defend their activities on the ground that they are trying to establish a patent market. Nathan Myhrvold, the CEO of Intellectual Ventures, the largest patent aggregation firm, describes his firm as "trying ... to create a capital market for inventions."
29 "To organize such a market," he says, "you need the liquidity that only investors can provide."
30
Several academic authors have made similar claims, observing that patent assertion entities really are intermediaries in the patent market. 31 As such, they "make the patent market more efficient by realigning market participant incentives, making patents more liquid, and clearing the patent market." 32 , 'speculators' invested in patents with the sole intention of profiting from the margins of price differentials, without participating in either inventive activity or manufacturing, much as a financial investor might trade in a share in a company in secondary and tertiary markets. In so doing, they added to the liquidity and depth of the market and enabled others to minimize their exposure to risk."); Kristen Osenga, Formerly Manufacturing Entities: Piercing the "Patent Troll" Rhetoric, 47 PAEs (and patent aggregators more generally) have made significant strides in adding liquidity, market clearing, and risk transfer mechanisms to the patent market. Their market participation by serving as "ready and willing" buyers of patents helps manage the supply of patents and provides liquidity to the patent market. Patent intermediaries' expertise in evaluating patent assets also leads to better information, more rational pricing, and lower transaction costs in the secondary market.
33
These observations and arguments are likely correct so far as they go. It is self-evident that more willing buyers create greater liquidity for patents, and that improving the notice function of the patent system will reduce the information costs associated with patent transactions. In short, there are many steps that policymakers and private sector actors can take to create more robust, liquid patent markets. But should they? There appears to be an underlying normative premise to these arguments: that those robust, liquid patent markets would be socially beneficial. That premise has, for the most part, 34 gone unexamined.
35
To challenge that premise, I draw upon the financial economics literature to develop the analogy between patent markets and financial markets. This analogy ultimately offers a mixed bag. There are some circumstances in which patent markets are likely to be socially desirable, but others in which they may be prone to well understood market failures. I begin by articulating the relevant normative standard, because transactional efficiency in itself is neither the goal of the patent system nor of financial markets. Indeed, efficient markets that match buyers and sellers of a particular asset are not usually thought to be ends in themselves; instead they are instrumentally useful when they serve other social goals, such as allocating useful goods and services or mitigating risk. Because the primary normative goal of the patent system is generally thought to be innovation promotion, the efficacy of patent markets ought to be judged not simply by CONN the extent to which they match buyers and sellers, but by the extent to which they promote or retard innovation. With this analogy in mind, there are two potential functions that robust patent markets can play. First, they can allocate technology. When patents correlate with technologically useful knowledge, markets can enable real technology transfer between inventors who need capital or skills and developers or commercializing agents who possess those things. That in turn has innumerable benefits because it allows for faster, better commercialization of new technologies. But where the fit between patents and technologies is imperfect, there is ample room for strategic behavior. A liquid market may exacerbate rather than ameliorate those behaviors because the pricing mechanism in a liquid market may more easily and quickly incorporate information about litigation value than commercialization value. In those circumstances, patents become inefficient assets. Their value in a market fails to reflect the value of the underlying technology. Market allocation of such assets may then be suboptimal from the perspective of social welfare.
Patent markets may produce similarly indeterminate results with respect to their second major function: allocating the various risks of innovation. On~ one hand, giving inventors an option to sell their patents rather than commercializing or enforcing them makes it far easier to earn a return, and thereby to mitigate the market risk of invention. Market pricing can also allow parties to mitigate infringement risk in a less costly manner than through litigation. But patent markets may give rise to a particular moral hazard problem in which inventors seeking only monetary returns no longer have an adequate incentive to monitor patent quality. The result is a dynamic not unlike that which affected markets for subprime mortgages and their associated securities in the late aughts. A market for an inefficient asset may simply produce more of that asset. If we take seriously, then, both the analogy between patents and financial assets and the normative goal of promoting innovation, the social value of patent markets becomes ambiguous. The difficult policy problem is to determine when one or another of these effects will dominate. That depends on a number of factors that are likely to be context-specific. How good a unit of technological exchange is a patent? How close is the fit in any given industry between patents and technologies? How many and what kinds of sellers and buyers are present in any given "sub-market" for a particular technology? And so forth. Understanding the dynamics of any particular patent market requires empirical research. This Essay therefore marks the beginning rather than the end of the conversation about patent markets. It offers a framework within which to carry out the difficult task of assembling empirical data. In the meantime, however, the theoretical discussion at least supports two related conclusions. First, patent markets are unlikely to be unqualified social goods. And, second, we therefore should not abandon efforts to improve patent quality in the mistaken belief that a well-functioning market will cure what ails our current system. I.
NORMATIVE BASELINES
A necessary first step in assessing the desirability of patent markets is to identify just what such markets are supposed to accomplish. The proponents of strong patent markets appear to view efficiency in patent transactions as the paramount normative goal. 36 To be sure, there are benefits to clearing the market-to allocating all given assets to those who are willing to pay market prices for those assets. But transactional efficiency is not the sole goal either of the patent system or, for that matter, of modem capital markets.
Begin with the patent system. The constitutional purpose of intellectual property is " [t] Though debate over the proper aims and scope of the patent system is legion, most agree that, at a minimum, it exists to promote innovation. 38 Patents can serve this purpose in several ways. 39 The classic justification for patents is that they provide incentives to invest in innovation. 40 It is usually thought that an unregulated market will under-supply innovation because it is risky and expensive, but its product-information-is cheap and easy to copy. 41 their inventions, patents render appropriable otherwise · rion-rivalrous and non-excludable information. This is turn allows those inventors potentially to recoup their investment in R&D, which would otherwise be free for others to take. 42 The grant of exclusive rights in an invention comes with social costs 43 : the static deadweight loss that arises from pricing information above its marginal cost (of zero), 44 and the dynamic social welfare losses that arise because information is an input into the downstream production of further information. 45 Most debates about the desirability of intellectual property, or of changes to existing intellectual property law, attempt to determine the magnitude of the tradeoff between these benefits and costs.
A variety of other potential justifications for patents have been proposed within the basic utilitarian framework. 46 Most relevant for the analysis of patent markets, and described in further detail below, 47 is the idea that patents play a role not only in invention but also in commercialization, the process of bringing an inventive product from conception through development to marketing. This justification is usually thought to have its origins in the work of Edmund Kitch, who analogized patents to mining claims, and argued that broad patents give their owners incentive to max1m1ze their value by controlling their development and cornrnercialization. 48 patents might play in facilitating innovation even after they issue. 49 They can provide incentives for commercialization 50 or they can facilitate linkages between inventors and sources of development expertise or financing. 51 Debate regarding the former mostly mirrors the debate over using patents to incentivize invention in the first instance. 52 There remain serious questions about whether a commercialization market failure exists and, if so, whether patents are the socially optimal solution to that market failure. 53 As to the latter, I have argued in previous work that patents are not necessary to facilitate the exchange of valuable information. 54 But as described in Section II.A, there may be instances in which they are useful to accomplish that goal, as loci for bargaining and for the exchange of tacit knowledge.
The point here is not to resolve these questions. It is instead to highlight the common normative backdrop: patents are not naturally occurring phenomena with a value-neutral allocation scheme. 55 They are "government interventions in the marketplace designed to achieve social policy ends." 56 They exist only to the extent that we continue to believe they produce more social welfare gains in the form of increased innovation than social welfare losses in denied access to those innovations. 57 Most debates about the patent system today concern whether particular changes to the substantive or 49 . For criticism of the theory that patents are justified by more than their ability to incentivize invention in the first instance, see Mark A. Lemley procedural rules governing patents will be better or worse for innovation. There is no reason why the system for allocating patent rights should be exempt from those debates. The question whether we should have liquid markets for patents, in other words, ought to be judged by the same standard as the question whether we should have patents at all. What about financial markets? Here too, liquidity and efficiency are not ends in themselves. Instead, the financial economics literature posits two goals for financial markets: allocating assets to their highest value uses, and allocating risk to the least-cost risk bearers. 58 Think, for instance, of futures contracts. These are contracts in which one party promises to deliver a certain amount of a commodity-say wheat, or copper-at a particular price on a particular date. 59 When a contract is bought and sold, the market allocates to the buying party both a claim to the underlying commodity and the risk that the price of that commodity will change.
60 The asset and the risk are allocated to the party that is willing to pay · a particular price, reflected in the market price of the contract, for those things.
61
Liquid markets aid this allocation in several ways. First, they provide price information by aggregating the preferences of buyers and sellers as expressed in market transactions. Second, they ensure the availability of opportunities for welfare enhancing transactions. The more willing buyers and sellers there are, the more likely it is that the socially optimal allocation will be achieved. Third, they lower transaction costs. They make it easier for buyers and sellers to find one another, thereby reducing "search costs." And they lower the cost of generating information necessary for those buyers and sellers to reach a negotiated bargain, usually by putting in place mechanisms that make it easier for market participants to assess the value and characteristics of the goods to be traded. 62 The important point, however, is that these functions of markets are instrumental. Liquidity makes it easier to transfer assets from one party to another. 63 [Ariz. St. L.J.
utility of markets is derivative of the social utility of the goods that trade on them.
The view that market efficiency is instrumental rather than a good in itself is reflected most clearly in the ongoing debates about financial innovation. "Financial innovation" refers to the development of new financial products such as derivatives, credit instruments, and various forms of tradable securities used to allocate risk, and their incorporation into the existing institutional structure of markets and intermediaries. 64 Were efficiency in the purchase and sale of financial products the sole goal of financial markets, . . one would think that markets in complex financial products would be generally unobjectionable. But a significant debate has emerged, particularly following the financial crisis of 2008-09 about the desirability of continued financial innovation. 65 In answering the question whether one or another particular financial instrument is socially valuable, participants in this debate usually draw a distinction between financial markets and the "real economy." 66 The latter comprises goods and services that are the subject of trades; the former comprises those instruments that are used either to fund the real economy or to guard against its risks.
67
Financial products, even if they are traded efficiently in a liquid market "are socially beneficial when they help people insure risks" 68 or when they allocate capital or commodities. But when they fail to carry out those functions, trading in them amounts to "gambling [which] can instead be socially detrimental."
69 It stands to reason that liquid markets for socially harmful products are themselves socially harmful.
Putting together the rationales for patents and for financial markets yields a normative baseline for the analysis that follows. Liquid markets for patents should be. evaluated based on the extent to which they promote innovation. After all, if patents are justified only to the extent that they are socially useful, it follows a fortiori that, markets in patents should only exist if they are socially useful.
A well-functioning patent market would carry out two distinct tasks. Like a market for futures contracts, as described above, or any other financial asset, it would allocate both the underlying asset and the risks associated with that asset. A patent is a time-limited, exclusive right to make, use, or sell a particular claimed invention. It is analogous to the futures contract. The underlying asset is not a commodity like wheat, but the invention that is the subject of the patent claims. 70 Assigning a patent to a particular person, either the inventor, as current law does as an initial matter, 71 or a subsequent market buyer, 72 allocates to that person both a claim to the underlying invention and a set of risks associated with that invention. A market for patents would allocate innovation's underlying asset-technology-and the dual risks of innovation and infringement. The next section will explore whether and how markets for patents might achieve socially useful allocations of those things.
II. EV ALU A TING PA TENT MARKETS
This Section envisions a hypothetical patent market and evaluates how well such a market might meet the normative goals described above. There are a number of different ways in which one might imagine patents being traded in a market. Patents could trade like stocks. To do so, they would have to be made fungible. That is, one share of common stock is no different from any other share of common stock; they are commodities. It may be possible to structure, say, a holding company whose only asset was a patent or a group of related patents, 73 and sell shares in that holding company. More likely, however, is that patents will remain bespoke rather than commoditized. That is, each patent is likely to remain unique and distinct from each other patent. Markets in such goods nevertheless can develop and function in predictable ways. The real estate market, for example, is often a liquid market in differentiated goods. So too are markets for certain financial products like derivatives.
To simplify the hypothetical patent market, I focus on three characteristics that would obtain regardless of its particular structure. The first is liquidity. The market would have enough willing buyers and sellers of patents that most contemplated trades would be executed. The second is price taking. No single player in the market would be so large as to unduly 70 . Note that although the underlying asset is the invention, it can be difficult in practice to separate the invention from the patent. See Martin & Partnoy, supra note 3, at 310-11.
71. influence the prices that the market generates. In other words, transactions would take place at the market-clearing price. Third, there would be enough institutional infrastructure to support transparency as to prices and characteristics of transacted patents.
To be sure, there are many complications. Two merit a few further words. First, in the contemporary, non-hypothetical market, many firms build packages of related patents that may be traded as a group. 74 The complementarity of patents in a portfolio often makes the value of the whole greater than the sum of its parts. 75 This phenomenon makes patent valuation particularly complicated, 76 and casts some doubt on whether individual patents and portfolios ought to be treated similarly. 77 Nevertheless, although valuation may be different with respect to individual or aggregated patents, the behavior of those two asset classes in a liquid market is likely to be similar. Second, the institutional details-what kinds of patents are being traded, who are buyers and sellers and what are their characteristics, who are the market makers and what are the rules that they set, how are trades recorded and publicized, and so on-do matter.
78 That said, the analysis that follows is, for the most part, neutral with respect to the institutional details.
A. Allocating Technology
One function a liquid patent market could play is to facilitate the exchange of useful technologies, helping to ensure that they wind up in the hands of their highest value users. In other words, the market for patents is like the market for secondhand goods. Patents usually are issued first to inventors: But just like the secondary market for tangible goods allocates a resource-vintage jeans, say-from an original to the subsequent user that values it the highest, so too can a secondary patent market use price signals to allocate technology to its highest and best use. More specifically, patent markets can link inventors with sources of development skill and financial capital to do what the inventors themselves cannot: bring a product from the laboratory to the shelf.
There is, however, a difference between markets for technology and markets for patents. And arguments for the former may not always justify the latter. It is blackletter patent law that patents are solely negative rightsthey are rights to exclude. 79 The simple analogy between markets for patents and for tangible goods is therefore not quite right. It is the technology that is analogous to the vintage jeans, not necessarily the patent. The underlying technology is a resource that can be put to productive use; the patent is a legally created right to prevent others from engaging in that use. When this right to exclude is similar in scope to the underlying technology, then it can aid in the technological exchange that I describe above. But when that fit is imperfect, the risk of strategic behavior may become significant. And in that case, the pricing function of liquid patent markets may not produce optimal results.
Patents and the Market for Technology
An account of the positive impact of liquid markets for patents in facilitating technological exchange begins with two premises: tech transfer is important; and it is difficult to accomplish. A wave of recent scholarship has emphasized the importance of commercialization. 80 Invention is merely the beginning of a broader process of innovation, in which new ideas not only are generated, but also are developed and brought to market. 81 Those latter functions, which are what catalyze real social benefits, often require skills that the initial inventor of a technology does not have. To bring those skills to bear and turn an idea into a useful product, an inventor usually must seek out others-development partners, product designers, manufacturing engineers, and so on. And commercialization is costly; often requiring more financial resources than inventors themselves may possess. But contracting over technology is notoriously difficult. Kenneth Arrow famously articulated a "fundamental paradox" that arises when parties try to contract for the sale of information. 82 The buyer of information must be able to place a value on the information and determine how much she is willing to pay. But once the seller discloses the information, the buyer is in possession of the subject of the trade and no longer has any reason to pay for it. 83 Intellectual property is one way to solve the paradox. If the information that parties want to trade is protected by a patent, then it can be disclosed freely without fear of misappropriation.
84 "With suitable legal measures," Arrow writes, "information may become an appropriable commodity. " 85 In previous work, I have criticized the reflexive turn to intellectual property to facilitate the exchange of valuable information.
86 Intellectual property is not in fact necessary to accomplish technological exchange, 87 and often it is not sufficient either. 88 Solving the disclosure paradox therefore does not offer an independent justification for intellectual property and changes to the contours of existing IP doctrines for the sake of facilitating transactions need to take account of the relative social welfare costs and benefits of other means by which parties might successfully engage in technological exchange.
89
All that said, there are circumstances in which patents can reduce the transaction costs of technological exchange; and some circumstances in which they may do so optimally when compared with the existing alternatives. 90 Most straightforwardly, patents can solve the disclosure paradox and create for the parties an identifiable res over which to bargain. bargain for the allocation of those rights. Assuming that the scope of the rights correlates with the scope of the technology, a transaction in the former very closely approximates a transaction in the latter. There is some historical evidence that patents played a significant role in establishing markets for technologies. 93 Merges argues more specifically that patents provide an especially effective form of "precontractual liability" that allows parties to make disclosures of information not protected by a patent while still holding_ negotiating partners liable for misappropriation of the related information that fall within the boundaries of the patent claim.
94 Kieff focuses on the notice function of the patent, arguing that as a public document, it serves as a "beacon" to draw together interested collaborators.
95
Patents can lower transaction costs even in the more common situation in which they themselves are insufficient to complete the technology transfer. Often the disclosure of the patent is not enough actually to practice the technology. Much technology transfer, for example, requires not only the transfer of patented knowledge, but also the transfer of tacit knowledge that is critical to practicing the patent. Notwithstanding that patents are supposed to be drafted in such a way as to "enable any person skilled in the art ... to make and use the same,"
96 the disclosure in the patent document is frequently insufficient to allow full exploitation of the underlying technology. 97 In that circumstance, different mechanisms such as personal connections and organizational integration must facilitate the transfer of the non-codified knowledge. 98 That knowledge is especially susceptible to the moral hazard problem reflected in the disclosure paradox. 99 transfers by "exploiting the complementarity between know-how and any other technology input that the licensor can use as a 'hostage,'" such as a patent. 100 In that circumstance, the transferring party can threaten to withhold the patented component of the technology, as it is legally entitled to do, should the transferee party misappropriate the tacit knowledge.
101
To sum, the strong case that patents are necessary for technology transfer is likely wrong, but there are circumstances in which patents will lower the costs of such transfer. Now add a liquid market. Patent markets are likely to reduce transactions costs further still because they act on different dimensions of the costs of trade. In a liquid market, buyers and sellers are transparent to one another. This lowers search costs, including both "explicit costs, such as the money spent to advertise one's intention to sell or purchase" the patents, and "implicit costs, such as the value of time spent in locating a counterparty." 102 The presence of a large number of potentially interested parties makes it much more likely that compatible inventors and developers will find one another. A liquid market could also lower the information costs associated with the transaction by standardizing information across market participants. 103 Finally, and perhaps most importantly, liquidity would provide some measure of price information that would ease the cost of negotiating from relatively uninformed positions.
Patent Liquidity and Pricing
The dynamic described above is most likely to obtain when the transfer of a patent enables the transfer of new and useful technology. 104 There are two circumstances in which that might fail to occur. The first is when a patent claims subject matter that is obvious or not novel. 104. A note on nomenclature: I use "technology" here as "an imprecise term for useful knowledge rooted in engineering and scientific discliplines, but also drawing from practice experience with production." ARORA ET AL., supra note 99, at 3. It is well understood that there is a difference between patents and marketed products. The distinction I draw here is somewhat different. I posit that there are meaningful units of technological exchange-complete technologies to be used in one or more product markets that can be the subject of transfer between their inventors and third party sources of development expertise and financing that need not necessarily correlate with products.
should not have issued in the first place, and therefore does not transfer technology that otherwise would have gone undeveloped. 105 An efficient market for trading invalid rights merely exacerbates the social welfare losses associated with those invalid rights. 106 I consider separately in Section 11.B whether markets may offer a second-best solution to the problem of "clearing" invalid patents.
But even valid and infringed patents may diverge from the scope of economically useful technology. Patents can be too broad or too narrow. When this happens, there is significant room for strategic behavior. Take two common examples: software and biotech. Software claims are often functional in nature and broad. 107 As a result, they tend to cover many different technologies that parties might exchange. In biotech, the opposite problem sometimes obtains. To the extent that biotech inventions are unduly narrow in scope, technological exchange requires aggregation of many different patents. 108 In either circumstance, patent holders have the ability to extract rents arguably in excess of the value of the underlying technology. 109 Both broad software patents and narrow biotech patents may be components of larger technologies. Because the threat of injunctive relief or of significant ( sometimes treble) damages, patent holders of this sort often have negotiating leverage. 110 And because of the cost and uncertainty of litigation, patent holders often can extract nuisance value settlements. The mismatch between patent scope and technological scope, in other words, gives rise to many of the behaviors most associated with socially costly patent trolling.
Patents are notoriously difficult to value. This should be unsurprising in light of the many contingencies described above that might affect the amount and timing of cash flows that a patent can generate. 112 While the standard economic analysis of financial assets posits that the value of the asset is net present value of future cash flows, 113 figuring out how to take the measure of those cash flows is difficult. Although professionals utilize a variety of methods, 114 economists and legal scholars have focused increasing attention on a concept of patents as options. 115 In this view, a patent confers upon its holder "the right but not the obligation to make further investments."
116 For the cost of procuring a patent (including the R&D expense of the invention in the first instance), a patent holder can obtain "the right, at various stages, to purchase a stream of expected cash flows associated with excluding others from developing patented subject matter. Patent holders can monetize this right by developing and commercializing the patent and/or by litigating, or threatening to litigate, the patent." 117 The value of the commercialization option will depend on the cost of developing the invention, 118 the likelihood that the invention will be successful, and the potential revenues that the invention may generate.
119
The litigation value depends on a different set of variables relating to the likelihood of success and cost of enforcing the patent in court. 120 When strategic behavior of the sort described above is possible, the value of the expected cash flows from these two means of exercising the patent option are likely to diverge even more significantly than in the ordinary case. That is the cost of litigation may be dwarfed by the possibility of a large number biotech, but there are numerous reasons to believe that it will be. 118. Commercialization here can refer either to commercialization by the patent holder alone or by her licensee. In either case, the option value of the patent is tied to the ultimate value of the invention in the market. See Cotropia, supra note 3, at 113 8.
119. As Martin and Partnoy write, "the expected cash flows associated with the patent are only those incremental cash flows that would result from the producer's being able to exclude others from selling the product." Martin & Partnoy, supra note 3, at 308.
120. See id. at 321-23.
of judgments from a diverse set of defendants who are exposed to a broad patent.
121
The difference between commercialization and enforcement is similar to the distinction that some draw between ex ante transactions, which occur "before the purchaser has obtained the technology through other means," and ex post transactions, which occur "after the firm accused of infringement has invested in creating, developing, or commercializing the technology." 122 My purpose here is not to engage the debate about the social value of ex post transactions, but instead to ask whether a liquid market is likely to allocate patents to parties whose primary aim is commercialization or enforcement.
The answer to that question depends on which value will be reflected in the market price on a liquid exchange. One of the main benefits of a liquid market, as described above, is that it provides pricing data. The value of the good is determined by the price at which willing buyers will engage in the trade-the market-clearing price. In a liquid market, information cost is a significant determinant of the market-clearing price. Because the information costs associated with determining litigation value often may be lower, market prices could more likely reflect litigation than commercialization value. This in turn has significant implications for the allocation of patent rights.
The starting point for figuring out how markets might price financial assets is usually the efficient capital markets hypothesis. 123 In its most basic form, the hypothesis states "that in a well-functioning securities market, the prices of [securities] will reflect predictions based on all relevant and available information." 124 More precisely, several forms of the theory posit "informational efficiency"-a condition in which investors cannot expect to make abnormal returns trading on information 125 -with respect to several different types of information. The "weak" form of the hypothesis holds that market prices incorporate the most public of, information: previous pricing information. The "semi-strong" and "strong" versions of the hypothesis extend that characteristic to all publicly and privately available information, respectively.
126
In a seminal contribution, Gilson and Kraakman described in detail the mechanisms by which information influences market price. 127 In their account, the incorporation of information into market price depends on the initial distribution of that information.
128 That initial distribution is itself a function of information costs.
129 If "capital market efficiency is a function of information costs, then economizing on information costs pushes the capital market in the direction of greater efficiency. "
130 That is to say, the market will achieve greater efficiency with less costly information than more; it will incorporate less costly information into prices more rapidly than more costly information.
This analysis suggests that prices in a liquid patent market will more rapidly incorporate information about litigation value than commercialization value when the former is less costly than the latter, and vice versa. It is difficult to predict which will be which, but in at least some cases, litigation data will be easier to obtain. Consider first the sources of information. Litigation documents, including and especially monetary judgments, are public. The information necessary to make a reasonable assessment of a patent's value in commercialization is highly private. The calculation of a value is also likely to be easier (though, to be sure, not necessarily easy) with respect to litigation. Assessing the strength of a patent in court proceeds at least in the context of well-established legal frameworks, even if the applicability of those frameworks to a particular patent is contingent. Assessing commercialization value, on the other hand, requires consideration of an enormous number of idiosyncratic variablespredictions about the likely market, whether the patent is being commercialized by the inventor or by the inventor working in concert with licensees, what the relative cost structure and competitive advantage of each might be, and so forth. All this is another way of saying that it is easier to generate litigation comparables than commercialization comparables. Sophisticated parties already are using big data techniques to assess the characteristics of litigated patents and make reasonable projections about how unlitigated patents might fare. 131 It is very difficult to undertake a similar exercise for the commercialization scenario. "Because of the unique nature of patents, the 'comparables' can always be distinguished." 132 Comparables become even more important for pricing in informationally inefficient markets that trade in non-fungible assets. The efficient capital markets hypothesis applies to markets in economic commodities, such as common stock. 133 Price aggregation works best when the prices of a large number of trades reflect the value of the same underlying asset. When those assets start to become differentiated from each other, the market price tends to reflect an estimate of value based on comparables. 134 Think of the real estate market as an example, in which the sale price of a house depends in no small part on the sale price of similar homes in similar geographies.
As described above, patents are quite different from one another; they are bespoke rather than commoditized financial assets. There are conceivable patent market structures that could achieve commoditization, such as selling shares in a portfolio or in a holding company whose only asset is a patent. 135 But because I want to remain neutral with respect to market structure, 136 my use of the efficient capital markets hypothesis here must necessarily be qualified: It is a hypothetical ideal. The less an actual patent market resembles this ideal, the less informationally efficient it is likely to be. Because even informationally efficient patent markets are likely to incorporate some types of information more easily than others, less efficient markets will a fortiori exhibit the same characteristics. Pricing in most patent markets, then, will reflect estimates of the values of comparable patents. Because comparables are often easier to obtain for litigation outcomes than for commercialization outcomes, it is likely that litigation value will dominate. I do not claim that this analysis will hold true in all circumstances. One variable that may affect pricing is the particular parties that comprise the market. Gilson and Kraakman describe the roles that various intermediaries play in the securities markets. They argue that different institutions are equipped to handle different sorts of information costs. The rate of incorporation of information therefore depends not only on the nature of the information cost but also on the characteristics of the institutions that operate in the market. 137 In patent markets, it is possible that even high cost ,.. information can be incorporated into the market price if the intermediaries are sufficiently able to process that information. Non-practicing entities in the current market, for example, are often praised for their ability to assess the value of patents.
138 But they most often do so on the basis of litigation value, because their expertise lies in patent enforcement and their function is akin to providing litigation finance. 139 But if the market becomes populated with operating companies that have expertise in commercialization, it stands to reason that they may make different assessments that feed into the market price.
A second variable is the possibility that developments in the law of patent damages might result in greater convergence between commercialization and litigation values. To the extent that the calculation of a "reasonable royalty" 140 more closely mirrors the economic contribution of the patent to an infringing device or process, then the litigation outcome should more closely mirror the commercialization outcome. 141 But there wjll likely still be circumstances where, because of strategic behavior, the divergence in value is insurmountable. 142 Ultimately, a liquid market that tends to price patents at their litigation value will tend to allocate those patents to parties who are more likely to realize that value through enforcement. There are reasons to think that allocation is suboptimal from the perspective of social welfare. Direct consumer welfare benefits come from commercialization, from bringing new technologies to market. Patent litigation is not inherently suspect, and indeed is the vehicle through which the benefits of the right to exclude are realized. But "[ w ]hen a company commercializes technology that it invented independently and later faces a patent assertion," the resulting judgment or license "provides no direct benefit to consumers." 143 Such assertions, moreover, increase commercializing entities' costs, leading some to argue that they are amount to a tax on innovation or to pure rent seeking. 144 Similarly, I do not mean to suggest that litigation or commercialization value is the "correct" price of a patent. 145 The economic value of a patent is generally understood to be the difference between the value of the patented technology and the next best alternative, assuming a free choice between the two. 146 The litigation value is likely to diverge farther from the economic value. This means that in a liquid market, a patent is likely to be an inefficient asset-it may fail to reflect the underlying value of the technology.
Notwithstanding the discussion above, I make no attempt to resolve here the question whether commercialization or litigation is more socially useful or reflect more clearly the economic value of a patent. My point here is more limited: the operation of a liquid patent market could bring about a particular allocation of patents among the actors in the market that results in a very different patent system from that which we currently enjoy. It means a shift from a system in which the right to exclude is allocated to the inventor to a system where the right to exclude is allocated to the highest bidder, who may then be incentivized to realize that value through enforcement. The implications of this system are complex. Suffice it to say that allocating patent rights solely through operation of the price system 145. Indeed, as Gilson and Kraakman explain, the efficient capital markets hypothesis was never meant to conflate informational efficiency with "fundamental efficiency." Properly understood, the hypothesis says nothing about whether markets will achieve correct pricing. See may bring about a host of socially undesirable results. 147 At the very least, we need to think through whether and how such a system would continue to satisfy our normative priors.
B. Allocating the Risks of Innovation
The second function of capital markets is to allocate risk, and here too the analogy yields mixed results when applied to patent markets. There are two kinds of risk that a liquid market could help to mitigate. The first is the "market risk" associated with innovative activity, and the second is "infringement risk" associated with others' patenting. A liquid market for patents could in theory allow inventors to relieve themselves of the risk of commercialization or litigation, while simultaneously allowing potential infringers to bargain for an efficient allocation of litigation risk. But it. is also possible that liquid patent markets could create more risk rather than less, either by drawing into the system patents that otherwise would be rationally under-enforced, or by skewing inventive activity towards patentability. Both of these effects occur because of the same inefficiencies in pricing discussed in the previous part. This leads to a conclusion that has been recognized elsewhere with respect to other markets: a liquid market for an inefficient asset may wind up producing more of the asset.
Reducing Market and Infringement Risk
Innovators face two different kinds of risks arising from their activities. The first is the risk associated with invention writ large. Invention is highly uncertain. Most inventions fail to become marketable products.
148 So while it is true that a patent provides an incentive to invent insofar as it mitigates the risk of misappropriation of one's invention by others who can copy it, the patent does nothing to mitigate ordinary market risk. The vast majority of inventors earn little to no return on their investment simply because there is no one else willing to license or develop the invention protected by the patent. This is so, by the way, across the spectrum of inventors, from individuals to startup companies to established ~nterprises. Much of corporate R&D fails as well. 149 Relatedly, even if there is economic value to a patent, inventors often cannot themselves capture that value through litigation. Litigation, of course, is costly, time consuming, and uncertain. 150 Many inventors lack the funds or ability to bring infringement actions. And even those who do may find the decision to invest in litigation to have negative net present value. The ability to sell a patent into a liquid market potentially helps to cure these defects.
Most straightforwardly, because a liquid market could lower search and information costs, as described above, 151 there is a better chance that patent holders who are not themselves in a position to commercialize or to litigate are more likely to find a partner who is. A liquid market might also, though, create more opportunities for patent holders to sell. There are a number of reasons why willing buyers might offer money in return for patents that cannot otherwise be monetized in the hands of their original inventors. It might be that a buyer with an existing portfolio will value a patent that is complementary to its existing holdings differently than a sole patent holder. 152 Other sources of liquidity might base their business models expressly on risk management. Mhyrvold sometimes describes Intellectual Ventures in these terms. 153 One of the benefits of a portfolio strategy is that it diversifies the cash flow returns from a large number of patents. 154 The value of the portfolio is less dependent on the cash flows from any particular patent. And given that most patents are valueless, 155 portfolios' performance is dependent largely on particularly valuable outlier patents. It is a rational strategy in this model to invest small sums of money in a large number of patents, most of which will fail to produce revenue, but a small number of which will produce outsized returns. 156 Entities that engage in this strategy therefore tend to be lower cost risk bearers than individuals or undiversified operating companies.
Furnishing inventors with an option to sell, in addition to the options to commercialize and litigate, 157 thus reduces each individual inventor's risk with respect to the likely cash flows from her patent. 158 This in tum arguably furnishes additional incentive to invent. 159 If inventors have greater assurance that they can achieve a return on their investment in inventive activity, they are more likely to undertake that activity. Because providing an incentive to invent is one of the core justifications for the patent system, 160 liquid patent markets may be normatively desirable. Along similar lines, a number of scholars have written about how patents can promote specialization in the innovation value chain. 161 Arora and Merges, for example, argue that patents "make it possible for technologyintensive inputs to be supplied by separate firms" through the process of market exchange.
162 "This, in turn, contributes to the viability of these specialized firms as standalone entities."
163 It stands to reason that improving the efficiency of exchange transactions through a liquid market lowers the transaction costs associated with specialization, and may contribute to easier specialization. 164 And there is some historical evidence that, in fact, liquid secondary markets contributed to the growth of specialized "invention firms." 165 To the extent that specialization promotes efficiency in innovation-and to the extent that we believe smaller firms to 156. See Myhrvold, supra note 4 ("A single invention is typically very risky. However, if you build (as my company has) a diversified portfolio of tens of thousands of inventions that span a wide range of technologies, the aggregate risk becomes quite manageable.").
157. See supra notes 108-14 and accompanying text.
158. One common complaint about current patent markets is that they function primarily to monetize patents for creditors when patent-heavy firms go bankrupt. See, e.g., FTC REPORT, supra note 12, at 70. But see Risch, supra note 19, at 489-90 (finding that most NPE patents are not obtained in bankruptcy transactions). Providing a backstop for bankrupt firms is another way to reduce risks; I do not attempt to compare the welfare effects of providing this backstop prior to bankruptcy. be more dynamic and innovative-then liquid patent markets may help to promote innovation through this mechanism as well. 166 The second kind of risk arising from patents is infringement risk. Patents are "probabilistic." 167 They are of uncertain validity and uncertain boundaries. As to the former, although patents enjoy a presumption of validity when they issue, 168 validity is not conclusively established until patents are tested in litigation. Empirical evidence suggests that this uncertainty is significant-some studies find that upwards of 45% of patents litigated to final judgment are found to be invalid. 169 The scope of even valid patents is also highly uncertain, and subject to the vagaries of claim construction, arguably the most contentious and difficult to predict aspects of patent litigation. 170 This uncertainty means that an issued patent presents a risk of infringement to those working in the same field as the patent. Patents purport to cordon off a range of activities that persons are not supposed to engage in without a license from the patentholder. 171 But because it is not clear either that those persons in fact cannot engage in the subject matter of the patent (i.e. that the patent is valid) or that those persons' activities are in fact within the exclusive right protected by the patent (i.e. that the boundaries are clear), it is very difficult to plan innovative investments. Often, innovative activity can be chilled by the mere presence of a patent, even if it is more likely than not that the activity can proceed. 172 This is especially true in view of the fact that investments in innovation need to be made over time, with the result of that innovation itself uncertain at the end of the investment period.
A liquid patent market might help mitigate this uncertainty by allowing the market for patents to clear. In a market where pricing is determined in no small part by litigation value, 173 entities can assess their exposure and, if it makes economic sense, mitigate their risk of infringement by buying the patent at the market clearing price rather than relying upon the vagaries of litigation. 174 Some defensive aggregators adopt this strategy as a business model. 175 Their clients invest in a fund that the aggregator uses to buy patents that pose a risk to the clients; the value proposition to clients is that the aggregator therefore clears infringement risk at a lower cost than in litigation. 176 (And, from the perspective of the patent owner, this market provides a far easier way to enforce her patent).
One objection to this purported benefit is that perhaps we do not want the market for invalid patents to clear. Transactions over exclusive rights that ought not to have issued in the first place are socially wasteful. Merges, for example, writes, "[t]he market for patents unrelated to innovation adds nothing to overall social welfare."
177 He analogizes invalid patents to the market for blackmail. 178 In such a market, the person who has damaging info'rmation and the person against whom the information may be used both be:aefit from a voluntary transaction in which the blackmailer gets paid, and the blackmailee does not suffer reputational harm. But it can hardly be said to improve social welfare. So too, the patent holder is made better off in a market transaction for her patent, and the potential infringer may buy patent peace at a lower price than the cost of litigation. But it is not clear this transaction is welfare enhancing.
The answer to this objection lies in weighing the cost of clearing the market for bad patents against the cost of reducing the prevalence of bad patents in the first instance. The United States Patent and Trademark Office ("PTO") received almost 600,000 patent applications in 2013, and issued over 300,000 patents. 179 There is no reason to believe that these numbers will decline any time soon. At that volume, it is extremely costly for the PTO to ensure that every issued patent is valid. Indeed, Mark Lemley has long argued that the PTO is "rationally ignorant" in applying a relatively light screen to patent applications. 180 This is because most patents are never the subject of litigation or licensing, so pose little social cost other than the cost of prosecution. 181 Those patents which prove valuable enough to assert are then adjudicated more closely in litigation. 182 As patent litigation, particularly as practiced by patent assertion entities, has grown, one of the common refrains has been to tighten standards at the PTO, to ensure that it issues fewer invalid or overbroad patents. 183 Congress has also authorized a set of administrative procedures in the PTO-"inter parties review" and "post grant review"-that appear to be viable avenues for challenging the validity of issued patents at a lower cost than through litigation. But the market solution described above may prove less socially costly. In other words, it might be the case that the market can clear bad patents at a lower overall social cost than PTO reform aimed at ensuring more rigorous examination of every patent. If the patent market clears risk at a market clearing price, then perhaps we do not have to worry about an oversupply of bad patents. The optimal solution to the problem of bad patents, of course, depends on the magnitude (and distribution) of the relative social costs.
Increasing Systemic Risk
It is also possible, however, that liquid patent markets could create more risk rather than less. There are two ways this could occur: First, the market could draw into the system patents that otherwise would have gone unenforced. Second, the market can encourage the production of more patents and, potentially, lower quality patents. The overall social welfare calculus depends on whether the benefits of risk reduction described above outweigh the costs of risk creation discussed below.
To begin, consider the flip side of Lemley's "rational ignorance" argument. The logic of tolerating a light screen at the PTO depends upon rational under-enforcement. 184 That is, it is rational to allow litigation to screen invalid patents rather than administrative processes only when it remains true that relatively few patents are asserted. If patent assertions begin to rise, then the social cost of invalid patents rises relative to the cost of screening out those patents.
Enter liquid markets. One potential effect of increasing liquidity is simply that more patents are now the subject of transactions than previously. As described above, the welfare effects of drawing more patents into the system this way are ambiguous. Of perhaps somewhat greater concern, more patents could wind up in litigation than in the absence of a liquid market. As described in Section II.A, when the fit between patents and technologies is imperfect, a liquid market may favor allocating patents based on their litigation value, and to those who are more likely to choose enforcement over commercialization or other options. 185 This means that patents traded on the market may disproportionately come to be held by entities who choose to realize the asset's predicted cash flows through litigation. The result, in tum, may be more patent litigation rather than less.
More troublingly, a liquid patent market would likely impact the primary behavior of innovators, skewing inventive activity toward patentability. There are a couple of ways in which this could be problematic. For one thing, inventors may find it more cost effective to rely on patent protection to appropriate the gains from their R&D investments than other less socially costly mechanisms for securing a return. Society could then be getting the same amount of innovation at a higher social cost. Alternatively, the attractiveness of securing a return on patentable inventions by selling the underlying patent into a liquid market could induce inventors to shift their activities toward things that are patentable rather than not, even where the latter may be more socially valuable. 186 This is a variation of the familiar argument that stronger patents rights yield not more innovation, but more patents. 187 Greater liquidity may, in some circumstances, generate more patents rather than more innovation.
How might this occur? Intuitively, the ability to monetize patents easily by selling them into a liquid market may lure more inventors to file more patents with a more secure expectation of garnering a return. More specifically, in the option calculation described above, 188 a sale option is likely to dominate the litigation and commercialization options because it is vastly more certain.· But there is a deeper problem with which the financial economics literature is familiar: moral hazard. Consider the growth of a secondary market for securities and derivatives of subprime mortgage loans in the mid-aughts. In this market, originators of mortgage loans-the banks that lent the initial capital to potential homeowners with poor credit-often packaged and sold financial instruments based on the underlying loans to third parties. When the extent of credit risk represented by those instruments became apparent, and the underlying mortgage loans began to default with greater frequency, this secondary market collapsed and the holders of the securities and derivatives faced significant losses when they were unable to liquidate their holdings for nearly the amount they paid. 189 The "dominant" explanation for the growth, and eventual collapse, of the subprime mortgage market is the "originate to distribute"· theory. 190 Prior to the mid-2000s, most mortgage financing followed an "originate to hold" model, in which mortgage lenders held at least some substantial portion of the loans they issued for the duration of those loans. 191 This was especially true for subprime loans, which generally could not be sold to the government-sponsored entities Fannie Mae and Freddie Mac. The development of a secondary market for subprime mortgages changed this dynamic, and the originators' business model increasingly shifted from one in which they kept their subprime loans on their own books to one in which they sold the loans in the secondary market to third-party buyers. 192 The moral hazard arose because originators, no longer residual claimants to the securities they packaged and sold, had no incentive to keep up their underwriting standards. They could originate highly risky loans because, once sold, they were no longer exposed to that risk. As a result, the quality of underwriting went down, and more and more risky loans entered the market. 193 To be sure, this explanation for the financial crisis is not without its critics. 194 But there is good empirical evidence to support the link between moral hazard and declining underwriting standards. 195 This dynamic maps well onto the participants in liquid patent markets. When inventors are active participants in ongoing innovation, they often face infringement risk commensurate with the risk they themselves generate. That is, practicing entities that produce patents may, by virtue of practicing in the relevant art, expose themselves to a risk of infringing others' patents. 196 While it is true that every patent holder has an incentive to draft her patent as broadly as possible, inventors who are exposed to symmetric risk have a countervailing incentive to monitor patent quality. This may be so at the retail level, wherein patentees will try to file applications that they are reasonably sure are valid and cover a range of technologies in order both to maximize their own chance of recovery and to have a strong counter-patent to use if they are sued. And it can also be true at the wholesale level. Witness attempts by many software companies to reform the law governing software patents.
If inventors can sell patents into a market in which they are no longer active participants-in which they no longer themselves have an interest in commercializing, or in which they no longer themselves face a symmetric risk of infringement liability from others-then their incentive · is not to monitor patent quality. It is instead to put plausible patents into the market without regard to whether they are sure bets either in commercialization or in litigation. Indeed, to the extent that a liquid patent market aids in the formation of a completely distinct "invention" sector, 197 participants in that sector will likely face incentives to generate and sell patents at a rapid clip. After all, that is the primary source of revenue generation in the business model. The result could be more and lower quality patents. This may expand rather than reduce the overall level of risk in the patent system.
III. IMPLICATIONS AND CONCLUSIONS
Applying the logic of financial economics to the patent system yields ambiguous results, at least as a matter of theory. Patent markets could lower search costs and generate pricing information that leads to more efficient transactions in technology, which everyone agrees is of great importance in fostering innovation up and down the supply chain. But where the fit between patents and technologies is imperfect, the patent becomes an inefficient unit of exchange and a liquid market could lead to significant strategic behavior. And while patent markets may help reduce both market risk and infringement risk to innovators, the financial economics literature tells us that a liquid market for an inefficient asset could simply result in the production of more of that asset.
Broadening the lens, this result should not be surprising. There are times when we think markets work well to allocate resources, and times when we think they do not. Stock markets, despite their flaws, generally do a good job allocating capital and diversifying risk. But we tend not to rely on markets to allocate other kinds of goods, particularly when we are concerned with distributive effects and moral hazard. The purchase and sale of human organs, for instance, is banned almost worldwide. And for good reason. It is commonly thought that, left to its own devices, a market for kidneys would crowd out altruistic donation, decrease supply, and increase prices with severe consequences for poor recipients, or would result in coercion of poor sellers with no reasonable economic alternative. 198 By now I have, perhaps overwhelmingly, analogized a hypothetical patent market to markets for stocks, 199 real estate,2°0 vintage jeans, 201 subprime mortgages, 202 and kidneys. 203 There is good reason to invoke all of these disparate markets: the patent market might look like one or all of them, depending on factors that are likely to be context-specific. It is well understood that the patent system, though nominally unitary, in fact often functions differently in different technological and business contexts. 204 As the discussion above demonstrates, the same is likely to be true of patent markets. The operation of patent markets will be industry-and technologyspecific. It will depend on the fit between patents and technologies, on the characteristics, economics, and business plans of the sources of liquidity and potential sellers in any given sub-market, and on the legal environment as well. Determining with any certainty whether a liquid patent market is socially useful in a particular context requires empirical research into the factors listed above and others. This Essay therefore cannot be predictive. I seek instead to open an agenda for research into the workings of nascent patent markets and their evolution, using the theoretical discussion herein as a framework and a guide.
The demonstrable need for a more nuanced understanding of patent markets calls into question the seemingly common assumption that patent markets are socially useful and that the only relevant policy question remains how to improve their function. It also puts the lie to the argument that if only we could make patent markets more robust and liquid, then the market would cure all that ails the patent system. It may be that the ongoing "financialization" of the patent system is useful in some contexts, but it cannot be a panacea for the problems that the patent system faces. In real terms, two conclusions follow. First, we should continue to make reforms to the patent system that are unambiguously useful and that may improve the operation of markets as well. Improving the notice function of patents is one such reform. But, second, we should not give up on reforms outside the context of markets in the hope that they will prove unnecessary. This is especially true with respect to patent quality. It is not clear that a market will eliminate bad patents at low social costs, and there is reason to think that the opposite result may in fact occur. Patent reform aimed at lowering the number of invalid patents or at better aligning the substantive standards of patent law to the innovation market failures it is supposed to correct will remain critically important.
